Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in Microsoft Word, RTF, or WordPerfect document file format.
  • Where available, URLs for the references have been provided.
  • The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.

Author Guidelines

The journal Medicine Today agrees to accept manuscript prepared in accordance with the 'Uniform Requirements Submitted to the Biomedical Journals' published in the New England Journal of Medicine 1991; 324: 424 8.

Aims and scope:
Medicine Today is a professional Medical Journal recognised by BMDC, published two times a year in January & July. It is devoted to continuing education in Medical Science. It accepts original articles, review articles, letter to the editor and case reports. Complimentary copies of the journal are sent to libraries of all medical and other relevant academic institutions in the country and selected institutions abroad.

Conditions for submission of manuscript:

  • All manuscripts are subject to peer review.
  • Manuscripts are received with the understanding that they are not under simultaneous consideration by any other journal.

  • Copyright:

    Copyright on any research article is transferred in full to Medicine Today upon publication in the journal. The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).

     

    Articles in the Medicine Today are Open Access articles published under a Creative Commons Attribution 4.0 International License (CC BY-NC 4.0). This License permits to use, distribution and reproduction in any medium, provide the original work is cited and not use for commercial purposes.

Ethical aspects:

  • Ethical aspect of the study will be very carefully considered at the time of assessment of the manuscript.
  • Any manuscript that includes table, illustration or photograph that have been published earlier should accompany a letter of permission for republication from the author(s) of the publication and editor/publisher of the Journal where it was published earlier.

Preparation of manuscript:

Criteria:
Information provided in the manuscript are important and likely to be of interest to an international readership.

Preparation:

    a) Manuscript should be written in English and typed on one side of A4 (290 x 210 cm) size white paper.
    b) Double spacing should be used throughout.
    c) Margin should be 5 cm for the header and 2.5 cm for the remainder.
    d) Each of the following section should begin on separate page:
    • Title page
    • Summary/Abstract
    • Text
    • Tables and legends
    • References
    • Acknowledgement

Title Page
The title page should contain:

  • Title of the article (concise, informative and self explanatory).
  • Name of each author with highest academic degree.
  • Name of the department and institute where the work was carried out.
  • Name and address of the author to whom correspondence regarding manuscript to be made. It should include e-mail address, mobile number.

Short Title:

Must be provided. These will be printed at the beginning of thr paper.

Abstract
The abstract of the manuscript:

  • Should be informative.
  • Should be limited to less than 250 words.
  • Should be suitable for use by abstracting journals and include introduction and materials and methods, results and conclusion.
  • Should emphasize mainly on new and important aspects of the study.
  • Should contain only approved abbreviations.

Text

Introduction:

  • Nature and purpose of the study.
  • Rationale of the study.
  • Brief review of the subject excepting data and conclusion.

Materials & Methods:
This section of the study should be very clear and describe:

  • The selection criteria of the study, population including controls (if any).
  • The methods and the apparatus used in the research.
  • The procedure of the study in such a detail so that other workers can reproduce the results.
  • Previously published methods (if applicable) with appropriate citations.

Results:
The findings of the research should be described here and it should be:

  • Presented in logical sequence in the text, tables and illustrations.
  • Described without comment.
  • Supplemented by concise textual description of the data presented in tables and figures where it is necessary.

  • Standard procedure to be maintained for statistical analysis. It should be done by a recognized statistician or subject expert related to statistics.

Tables:
During preparation of tables following principles should be followed:

  • Tables should be simple, self explanatory and supplement, not duplicate the text.
  • Each table should have a title and typed in double space in separate sheet.
  • They should be numbered consecutively with roman numerical in order of text. Page number should be in the upper right corner.
  • If abbreviations are to be used, they should be explained in footnotes.

Figures and photographs:
The figures and photographs.

  • Should be used only where data can not be expressed in any other form.
  • Should be unmounted glossy print in sharp focus, 12.7 x 17.3 cm in size.
  • Should bear number, title of manuscript, name of corresponding author and arrow indicating the top on a sticky, label and affixed on the back of each illustration.
  • Should be mentioned source of Illustrations and Figures.

Legend:
The legend:

  • Must be typed in a separate sheet of paper
  • Photomicrographs should indicate the magnification, internal scale and the method of staining.

Discussion:
The discussion section should reflect:

  • The authors' comment on the results and to relate them to those of other authors.
  • The relevance to experimental research or clinical practice.
  • Well founded arguments.
  • Brief acknowledgement at end.

Conclusion:

  • Clearly explain the main focus of the work highligting its importance and relevance including any practical application

Conict of Interests: Should include a statement.

Acknowledgements:
Individuals, organizations or bodies may be acknowledged in the article and may include:

  • Name (or a list) of funding bodies
  • Name of the organization(s) and individual(s) with their consent.

Abbreviations and Symbols:

  • Use only standard abbreviations.
  • Avoid abbreviations in the title of the article.

References:
This section of the manuscript:

  • Should be numbered consecutively in the order in which they are mentioned in the text.
  • Should be identified in the text by superscript in numerical.
  • Should in in Vancouver style.

National Library of Medicine and used in Index Medicus. The authors are responsible for the correctness of references. References are numbered consecutively in the order in which they appear in the text. Citations should be in superscript without bracket and should appear in front of the period or comma at the end of the sentence/clause. All references should be cited.

Unpublished data, personal communications, abstracts at meetings and manuscripts submitted for publication are not acceptable as references. References should be listed in numerical order in the Reference section. Journal titles should be abbreviated according to the list of Journals Indexed in Index Medicus or MEDLINE. Please note that no periods are used after the authors initials. A period is used at the end of each reference. The type and punctuation of references is consistent with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors (http://www.ICMJE.org/). Some examples follow.

Journal article up to six authors ( list all authors )
Smithline HA, Mader TJ, Ali FM, Cocchi MN. Determining pretest probability of DVT: clinical intuition vs. validated scoring systems. N Engl J Med. 2003 Apr 4;21(2):161-2.

Journal article more than six authors (list first six and add et al.):
Gao SR, McGarry M, Ferrier TL, Pallante B, Gasparrini B, Fletcher JR, et al. Effect of cell confluence on production of cloned mice using an inbred embryonic stem cell line. Biol Reprod. 2003;68(2):595-603.

Book:
Carlson BM. Human embryology and developmental biology. 3rd ed. St. Louis: Mosby; 2004.

Chapter in a book:
laxter PS, Farnsworth TP. Social health and class inequalities. In: Carter C, Peel JR, editors. Equalities and inequalities in health. 2nd ed. London: Academic Press; 1976: 165-78.

Conference proceedings: Harnden P, Jo_e JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.

Scientic or technical report: Akutsu T. Total heart replacement device. Bethesda MD: National Institutes of Health, National Heart and Lung Institute; 1974 Apr. Report No.: AFRLSRBLTR0 20123.

Dissertation: Borkowski MM. Infant sleep and feeding: a telephonesurvey of Hispanic Americans [thesis/dissertation].  Michigan: Central Michigan University; 2002.

Websites: WHO, 2010. Avian inuenza – situation in Vietnam- update 8. Available: http://www.who.int/csr/don/201 0_03_04a/en/index.html. All References Should include the possible DOI and PMid numbers.

Manuscript submission:
Manuscript should include hard and soft copy. No manuscript will be considered without hard and soft copy. It should be submitted to the Editor in Chief and must be accompanied by a covering letter and following inclusions:

  1. a) A statement regarding the type of article being submitted.
  2. b) A statement that the work has not been published or submitted for publication elsewhere.
  3. c) A statement of financial or other relationships that might lead to a conflict of interests.
  4. d) A statement that the manuscript has been read, approved and signed by all authors.
  5. e) If the article is a whole or part of the dissertation or thesis submitted for diploma/degree, it should be mentioned in detail and in this case the name of the investigator and guide must be specifically mentioned. Submissions must be in triplicates with three sets of illustrations. Text must be additionally submitted in a compact disc (CD).

Editing and peer review:
All submitted manuscripts are subject to scrutiny by the Editor in chief or any member of the Editorial Board. Manuscripts containing materials without sufficient scientific value and of a priority issue, or not fulfilling the requirement for publication may be rejected or it may be sent back to the author(s) for resubmission with necessary modifications to suit one of the submission categories. Manuscripts fulfilling the requirements and found suitable for consideration are sent for peer remit, Wt Submissions, found suitable for publication by the reviewer, may need revision/ modifications before being finally accepted. Editorial Board finally decides upon the publishabillty of the reviewed and revised/modified submission. Proof of accepted manuscript may be sent to the authors, and should be corrected and returned to the editorial office within one week. No addition to the manuscript at this stage will be accepted. All accepted manuscript are edited according to the Journal's style.

Subscription information:
Journal of Medicine Today ISSN 1810-1828 published by the Dr. Md. Lokial Ullah. Director Marketing, BIOPHARMA LAB. LTD. two times a year in January and July.

Address of correspondence:
Manuscripts and other communication for the editors should be address to
Medicine Today, Medical Services Department.
Biopharma Limited. Corporate Office: House No. 01
Commissioner Lane, Dhaka Housing , Adabor
Dhaka-1207
Bangladesh
e-mail: medicinetoday@biopharmabd.com
Phone: +8801711465704, +8801714096030. 

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)